Chenodeoxycholic acid |
|||||||
Cat.No.£ºIC-015568 |
|||||||
Product Information |
|||||||
Biological Activity |
|||||||
Chenodeoxycholic acid (CDCA) and Deoxycholic acid (DCA) both inhibit 11 beta HSD2 with IC50 values of 22 mM and 38 mM, respectively and causes cortisol-dependent nuclear translocation and increases transcriptionalactivity of mineralocorticoid receptor (MR)[1]. Chenodeoxycholic acid is able to stimulate Ishikawa cell growth by inducing a significant increase in Cyclin D1 protein and mRNA expression through the activation of the membrane G protein-coupled receptor (TGR5)-dependent pathway[2]. Chenodeoxycholic acid (CDCA) induces LDL receptor mRNA levels approximately 4 fold and mRNA levels for HMG-CoA reductase and HMG-CoA synthase two fold in a cultured human hepatoblastoma cell line, Hep G2[3]. Chenodeoxycholic acid-induced Isc is inhibited (¡Ý67%) by Bumetanide, BaCl2, and the cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor CFTRinh-172. Chenodeoxycholic acid-stimulated Isc is decreased 43% by the adenylate cyclase inhibitor MDL12330A and Chenodeoxycholic acid increases intracellular cAMP concentration[4]. Chenodeoxycholic acid treatment activates C/EBP¦Â, as shown by increases in its phosphorylation, nuclear accumulation, and expression in HepG2 cells. Chenodeoxycholic acid enhances luciferase gene transcription from the construct containing -1.65-kb GSTA2 promoter, which contains C/EBP response element (pGL-1651). Chenodeoxycholic acid treatment activates AMP-activated protein kinase (AMPK), which leads to extracellular signal-regulated kinase 1/2 (ERK1/2) activation, as evidenced by the results of experiments using a dominant-negative mutant of AMPK¦Á and chemical inhibitor[5]. |
|||||||
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines) |
|||||||
Species |
Mouse |
Rat |
Rabbit |
Guinea pig |
Hamster |
Dog |
|
Weight (kg) |
0.02 |
0.15 |
1.8 |
0.4 |
0.08 |
10 |
|
Body Surface Area (m2) |
0.007 |
0.025 |
0.15 |
0.05 |
0.02 |
0.5 |
|
Km factor |
3 |
6 |
12 |
8 |
5 |
20 |
|
Animal A (mg/kg) = Animal B (mg/kg) multiplied by (Animal B Km / Animal A Km) |
|||||||
Chemical Information |
|||||||
Molecular Weight |
392.57 |
||||||
Formula |
C24H40O4 |
|
|
|
|
|
|
CAS Number |
474-25-9 |
||||||
Purity |
>98% |
|
|
|
|
|
|
Solubility |
¡Ý 50 mg/mL (127.37 mM) in DMSO |
||||||
Storage |
at -20¡ãC |
|
|
|
|
|
|
References Information |
|||||||
[1]. Stauffer AT, et al. Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. J Biol Chem. 2002 Jul 19;277(29):26286-92 |
Order Information |
|||||
Cat./REF. |
Size |
Price($£© |
Price(€) |
Price(£¤/CNY£© |
Price(£¤/JYP£© |
IC-015568 |
100mg |
$50.00 |
€ 60.00 |
£¤500.00 |
£¤9,950.00 |
IC-015568 |
1g |
$150.00 |
€ 180.00 |
£¤1,500.00 |
£¤29,850.00 |
IC-015568 |
5g |
$520.00 |
€ 624.00 |
£¤5,200.00 |
£¤103,480.00 |
IC-015568 |
10g |
$850.00 |
€ 1,020.00 |
£¤8,500.00 |
£¤169,150.00 |
We Devoted Ourselves To The Development Of Biomedical Research Reagent. |